25 September 2026
The single exit price for medicines will rise 2.88% from October as the industry warns rising input costs are straining medicine supply.
23 September 2026
Medical scheme contributions face renewed scrutiny as BHF challenges the CMS's 3.8% guidance for 2027. See what is driving the cost pressure.
21 September 2026
Acute pain in African hospitals affects two-thirds of patients - what the burden means for hospital groups and medical schemes.
20 September 2026
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
19 September 2026
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
18 September 2026
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn - beating its R7bn Impact target a year early.
18 September 2026
Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.
18 September 2026
GLP-1 medicines alone can't solve SA's diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.
18 September 2026
Aspen's turnaround hinges on filling its underused sterile manufacturing plants, as GLP-1 sales drive a share recovery.
15 September 2026
The US healthcare affordability crisis is squeezing small employers the hardest, a mirror for local medical scheme debates.
14 September 2026
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
14 September 2026
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.